Activity slowed in the first quarter as AI disruption, private credit pressures and geopolitical uncertainty weighed on the market, according to Bain & Company’s latest PE report.
Canadian fundraising slumped in 2025, though it was a record year for private equity investment in the country.
The combination of the two firms, which will create the world's largest healthcare private equity investor, will change how healthcare investing is done by linking East and West opportunities, its co-chief executives tell PEI.
AI, geopolitics, ageing assets and the rise of continuation funds are weighing on private equity's value creation initiatives.
Documents prepared for an LP investment committee meeting reveal details of the GP stakes giant's approach to generating liquidity.
The UK has a strategic opportunity to become a global hub for defence investment, but it risks squandering that opportunity through regulatory frameworks that repel the very capital it needs to compete, writes Anthony Catachanas, founding partner and group chief executive of Tower Peak Partners.
In the rush to extend private markets access to new investors, the industry risks mistaking more products for better portfolios, writes John Toomey, chief executive of HarbourVest Partners.
In the second instalment of PEI’s new podcast miniseries, we analyse the key findings from Secondaries Investor’s inaugural Global Market Survey.
In today's edition, A 'democratisation' expert says GPs will only get one chance to deliver; Blackstone reckons evergreen 'tests' are helpful for the industry; New Mountain wants to deepen its Korea ties.
After a surge in interest around the covid-19 pandemic, it has been a mixed picture for life sciences and biotech-focused PE fundraising and capital deployment.